J Gomez-Navarro

Phase I study of tremelimumab (CP-675 206) plus PF-3512676 (CPG 7909) in patients with melanoma or advanced solid tumours

M. Millward, J. Gómez-Navarro, M Millward, 2013, British Journal of Cancer.